Frankfurt am Main
capsensixx AG with significant increase in earnings 01.01.-30.09.2021
* Earnings before taxes: EUR 6.2 million (previous year: +29.4. %)
* DVFA epS 30/09/2021: EUR 0.63 (previous year: +31.7 %)
Frankfurt am Main, 09/11/2021
The following key figures for the years 2020 and 2021 are given before deduction of third party shares, unless otherwise indicated.
In the first nine months of 2021, EBITDA increased by 8.9 % to EUR 6.8 million compared to the same period in 2020 (EUR 6.2 million).
Consolidated earnings before taxes for the first nine months of the financial year 2021 were EUR 6.2 million. Compared to the same period of the previous year (EUR 4.8 million), this represents an increase of EUR 1.4 million (+29.4 %).
Earnings after taxes (without non-controlling interests) increased to EUR 2.0 million (+22.8 %) in the first nine months of the financial year 2021 (previous year: EUR 1.7 million).
The first nine months of the 2021 financial year of the capsensixx Group exceeded the plan data and show a very positive and sustainable profitable operational development. If the market environment remains unchanged, the Management Board expects an ongoing increase in earnings concerning the further course of the financial year 2021. In the medium term, it is also expected that the high level of investment will further increase the growth trend.
The Nine-Month- Report 2021 of capsensixx AG will be available from November 29, 2021 at www.capsensixx.de/berichte/
60325 Frankfurt am Main
|Contact Person:||Martin Stuerner|
|Phone:||+49 69 7680585-25|
|Stock Exchange(s):||Regulated Market in Frankfurt, Free Market in Berlin, Free Market in Dusseldorf, Free Market in Munich, Free Market in Stuttgart, Open Market in Tradegate|